SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
Amendment No. 3
INMEDICA DEVELOPMENT CORPORATION
- --------------------------------------------------------------------------------
(Name of Issuer)
Common Stock $.001 par value
- --------------------------------------------------------------------------------
(Title of Class of Securities)
457639104
- --------------------------------------------------------------------------------
(CUSIP Number)
Mr. Larry E. Clark
1036 Oak Hills Way
Salt Lake City, Utah 84108 801-582-1733
- --------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person Authorized to Receive
Notices and Communications)
September 5, 1997
- --------------------------------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to
report the acquisition which is the subject of this Schedule 13D, and is
filing this schedule because of Rule 13d-1(b)(3) or (4), check the
following box [ ].
Check the following box if a fee is being paid with this statement [ ]. (A
fee is not required only if the reporting person: (1) has a previous
statement on file reporting beneficial ownership of more than five percent
of the class of securities described in Item 1; and (2) has filed no
amendment subsequent thereto reporting beneficial ownership of less than
five percent of such class. See Rule 13d-7.)
1
<PAGE>
CUSIP No. 457639104
-----------------------------------------------------------
1) Names of Reporting Persons S.S. or I.R.S. Identification
Nos. of Above Persons
Larry E. Clark ###-##-####
-----------------------------------------------------------
2) Check the Appropriate Box if a Member of a Group
(a)
------------------------------------------------------
(b)
------------------------------------------------------
3) SEC Use Only
------------------------------------------------
4) Source of Funds (See Instructions) PF
--------------------------
5) Check if Disclosure of Legal Proceedings is Required
Pursuant to Items 2(d) or 2(e)
------------------------------
6) Citizenship or Place of Organization U.S.A.
-----------------------
7) Sole Voting Power 1,593,000
Number of Shares ------------------
Beneficially Owned
by Each Reporting 8) Shared Voting Power 0
Person With ---------------
9) Sole Dispositive Power 1,593,000
-------------
10) Shared Dispositive Power 0
----------
11) Aggregate Amount Beneficially Owned by Each Reporting
Person 1,593,000
---------------------------------------------------
12) Check if the Aggregate Amount in Row (11) Excludes
Certain Shares (See Instructions)
------------------------
13) Percent of Class Represented by Amount in Row (11) 18.9%
------
14) Type of Reporting Person (See Instructions) IN
--------------
2
<PAGE>
Item 1. Security and Issuer
Common Stock, $.001 par value
InMedica Development Corporation
60 South 600 East, Suite 150
P.O. Box 27557
Salt Lake City, Utah 84127
Item 2. Identity and Background
(a) Larry E. Clark, an individual
(b) 1036 Oakhills Way
Salt Lake City, Utah 84108
(c) CEO
InMedica Development Corporation
60 South 600 East, Suite 150
Salt Lake City, Utah 84102
(d) No criminal convictions during past 5 years.
(e) No involvement in civil proceedings regarding federal or state
securities law violations during the past five years.
(f) United States of America citizenship
Item 3. Source and Amount of Funds or Other Consideration
Personal Funds
Item 4. Purpose of the Transaction
The Reporting Person acquired 450,000 shares by the exercise of
options. The Reporting Person has no present plans or proposals that
would result in any of the following:
(a) The acquisition by any person of additional
securities of the issuer;
(b) An extraordinary corporate transaction, such as a merger,
reorganization or liquidation, involving the issuer or any of
its subsidiaries;
(c) A sale or transfer of a material amount of assets of the
issuer or any of its subsidiaries;
3
<PAGE>
(d) Any change in the present board of directors or management of
the issuer, including any plans or proposals to change the
number of directors or to fill any existing vacancies on the
board, except that the Board of Directors is presently
searching for an acceptable person to serve as a fifth
director on the board, which would fill an existing vacancy;
(e) Any material change in the present capitalization or dividend
policy of the issuer;
(f) Any material change in the issuer's business or corporate
structure, including but not limited to, if the issuer is a
registered closed-end investment company, any plans or
proposals to make any changes in its investment policy for
which a vote is required by Section 13 of the Investment
Company Act of 1940;
(g) Changes in the issuer's charter, bylaws or instruments
corresponding thereto or other actions which may impede the
acquisition of control of the issuer by any person;
(h) Causing a class of securities of the issuer to be de-listed
from a national securities exchange or to cease to be
authorized to be quoted in an inter-dealer quotation system of
a registered national securities association;
(i) A class of equity securities of the issuer becoming eligible
for termination of registration pursuant to Section 12(g) (4)
of the Act; or
(j) Any action similar to any of those enumerated above.
Item 5. Interest in Securities of Issuer
(a) Mr. Clark holds 1,593,000 shares of common stock of the
Company (18.9%).
(b) Shared voting and dispositive power: None Sole voting and
dispositive power: 1,593,000 shares.
(c) During the past 60 days the Reporting Person has not purchased
or sold securities of the issuer, except the exercise of
450,000 options at $.30 per share to acquire 450,000 shares of
common stock.
(d) No person other than the Reporting Person has the right to
receive or direct dividends or sale proceeds from the
securities;
4
<PAGE>
(e) The Reporting Person remains a beneficial owner of more than
5% of this class of securities.
Item 6. Contracts, Arrangements, Understandings or Relationships with
Respect to Securities of the Issuer
There are no contracts, arrangements, understandings or
relationships between the Reporting Person and any person with respect to
transfer or voting the securities acquired and disposed of in this transaction,
finders fees, joint ventures, loan or option arrangements, put or calls,
guarantees of division of profits or losses, or the giving or withholding of
proxies.
Item 7. Exhibits
None
Signature.
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
September 10, 1997
---
/s/ Larry E. Clark
-----------------------------
Larry E. Clark
5
